Drugs / AJH-2947
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06155487 | Dec 2023 → Apr 2025 overdue | diabetic neuropathy, neuropathy, painful, postherpetic neuralgia | JMackem Co., Ltd | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AJH-2947 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06155487 ↗ |
| Route | Oral | “Oral Tablet” NCT06155487 ↗ |